Oral Care Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Oral Care Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Oral Care Market

The oral care market size was valued at USD 32.61 billion in 2023, and the market is now projected to grow from USD 33.63 billion in 2024 to USD 46.52 billion by 2032, exhibiting a CAGR of 4.14% during the forecast period of 2024-2032.

The production process of oral hygiene products is impacted by the significant worker movement from urban to rural regions. The rising cost of raw materials and the scarcity of vendor-supplied packaging materials were further challenges for producers. The COVID-19 pandemic and subsequent job losses and declining purchasing power of the worldwide populace have slowed down demand for these goods. A vast number of industries took a drastic forceful hit during the Covid period. These factors affected the oral care market growth.

Nowadays, the majority of dental illnesses that affect people are typical ones like tooth decay, oral cancer, and foul breath. Consumer demand for oral care products has increased as a result. A increasing number of dental offices and cosmetic stores, as well as increased consumer awareness of health and cleanliness, along with rising population income, are driving market expansion. These factors affected the oral care market share.

In order to address patients' additional personal care demands, a growing number of dentists now concentrate on providing basic oral caries and aesthetic spa services. This particular product market is driving and its revenue is off the charts because of this trend single handedly. The desire for associated dental cosmetic items may increase as a result of the patient experiencing less dental-related anxiety triggers throughout the procedure, including as visual, auditory, and olfactory stimuli.

Comprehensive Analysis of Oral Care Market

The market is divided into segments based on product type, including toothpaste, toothbrushes, mouthwash, and others. The market is split into residential and commercial segments based on application. The market is divided into hypermarkets/supermarkets, convenience stores, internet retailers, and other categories based on distribution.

Asia Pacific is expected to be the leading region of this particular product market and is anticipated to to grow over the forecasted period and also will continue to hold the largest market share.Because there are a lot of elderly people living in these countries, the Asia Pacific area has a dominant market. Tooth loss, dental decay, and gum disease are more common in the elderly population.

Moderate market fragmentation exists. In addition to spending money on R&D to manufacture items, these businesses have large production capacities. Colgate Palmolive Co. (U.S.), Unilever (U.K.), Procter & Gamble Co. (U.S.), Henkel AG & Co. KG aA (Germany), and Johnson & Johnson Services, Inc. (U.S.) are some of the major competitors of this particular product market.

In November 2021, The 100% recyclable plastic toothbrush handle was introduced by Colgate Palmolive. Transitioning to renewable energy with this launch will help lower the carbon footprint.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 4.14% from 2024 to 2032

Unit Value (USD Billion)

Segmentation By Product Type

Toothpaste

Toothbrush

Mouthwash

Others

By Application

Household

Commercial

By Distribution Channel

Hypermarket/Supermarket

Convenience Stores

Online Sales Channel

Others

North America (By Product Type, Application, Distribution Channel, and by Country)

The U.S. (By Product Type)

Canada (By Product Type)

Mexico (By Product Type)

Europe (By Product Type, Application, Distribution Channel, and by Country)

Germany (By Product Type)

France (By Product Type)

Italy (By Product Type)

Spain (By Product Type)

The U.K. (By Product Type)

Rest of Europe (By Product Type)

Asia Pacific (By Product Type, Application, Distribution Channel, and by Country)

China (By Product Type)

India (By Product Type)

Japan (By Product Type)

South Korea (By Product Type)

Australia (By Product Type)

Rest of Asia Pacific (By Product Type)

South America (By Product Type, Application, Distribution Channel, and by Country)

Brazil (By Product Type)

Argentina (By Product Type)

Rest of South America (By Product Type)

The Middle East and Africa (By Product Type, Application, Distribution Channel, and by Country)

South Africa (By Product Type)

UAE (By Product Type)

Saudi Arabia (By Product Type)

Rest of the Middle East and Africa (By Product Type)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Market Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Cancer, By Region/Country, 2023
4.2. Overview of Different Oncology Drugs With Respect to Regulatory Approvals and Clinical Trials
4.3. Pricing Analysis, Key Brands / Key Players, 2023
4.4. Key Industry Development (Mergers, Acquisitions and Partnerships)
4.5. Impact of COVID-19 on the Market
5. Global Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Drug Class
5.1.1. Cytotoxic Drugs
5.1.1.1. Alkylating Agents
5.1.1.2. Antimetabolites
5.1.1.3. Others
5.1.2. Targeted Drugs
5.1.2.1. Monoclonal Antibodies
5.1.2.2. Others
5.1.3. Hormonal Drugs
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Therapy
5.2.1. Chemotherapy
5.2.2. Targeted Therapy
5.2.3. Immunotherapy
5.3. Market Analysis, Insights and Forecast – By Indication
5.3.1. Lung Cancer
5.3.2. Stomach Cancer
5.3.3. Colorectal Cancer
5.3.4. Breast Cancer
5.3.5. Prostate Cancer
5.3.6. Others
5.4. Market Analysis, Insights and Forecast – By Dosage Form
5.4.1. Solid
5.4.1.1. Tablets
5.4.1.2. Capsules
5.4.2. Liquid
5.4.3. Injectable
5.4.3.1. Prefilled Syringes
5.4.3.2. Others
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.5.1. Hospital Pharmacies
5.5.2. Retail Pharmacies
5.5.3. Online Pharmacies
5.6. Market Analysis, Insights and Forecast – By Geography
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Drug Class
6.1.1. Cytotoxic Drugs
6.1.1.1. Alkylating Agents
6.1.1.2. Antimetabolites
6.1.1.3. Others
6.1.2. Targeted Drugs
6.1.2.1. Monoclonal Antibodies
6.1.2.2. Others
6.1.3. Hormonal Drugs
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Therapy
6.2.1. Chemotherapy
6.2.2. Targeted Therapy
6.2.3. Immunotherapy
6.3. Market Analysis, Insights and Forecast – By Indication
6.3.1. Lung Cancer
6.3.2. Stomach Cancer
6.3.3. Colorectal Cancer
6.3.4. Breast Cancer
6.3.5. Prostate Cancer
6.3.6. Others
6.4. Market Analysis, Insights and Forecast – By Dosage Form
6.4.1. Solid
6.4.1.1. Tablets
6.4.1.2. Capsules
6.4.2. Liquid
6.4.3. Injectable
6.4.3.1. Prefilled Syringes
6.4.3.2. Others
6.5. Market Analysis, Insights and Forecast – By Distribution Channel
6.5.1. Hospital Pharmacies
6.5.2. Retail Pharmacies
6.5.3. Online Pharmacies
6.6. Market Analysis, Insights and Forecast – By Country
6.6.1. U.S.
6.6.1.1. By Drug Class
6.6.2. Canada
6.6.2.1. By Drug Class
7. Europe Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Drug Class
7.1.1. Cytotoxic Drugs
7.1.1.1. Alkylating Agents
7.1.1.2. Antimetabolites
7.1.1.3. Others
7.1.2. Targeted Drugs
7.1.2.1. Monoclonal Antibodies
7.1.2.2. Others
7.1.3. Hormonal Drugs
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Therapy
7.2.1. Chemotherapy
7.2.2. Targeted Therapy
7.2.3. Immunotherapy
7.3. Market Analysis, Insights and Forecast – By Indication
7.3.1. Lung Cancer
7.3.2. Stomach Cancer
7.3.3. Colorectal Cancer
7.3.4. Breast Cancer
7.3.5. Prostate Cancer
7.3.6. Others
7.4. Market Analysis, Insights and Forecast – By Dosage Form
7.4.1. Solid
7.4.1.1. Tablets
7.4.1.2. Capsules
7.4.2. Liquid
7.4.3. Injectable
7.4.3.1. Prefilled Syringes
7.4.3.2. Others
7.5. Market Analysis, Insights and Forecast – By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Retail Pharmacies
7.5.3. Online Pharmacies
7.6. Market Analysis, Insights and Forecast – By Country/Sub-region
7.6.1. U.K
7.6.1.1. By Drug Class
7.6.2. Germany
7.6.2.1. By Drug Class
7.6.3. France
7.6.3.1. By Drug Class
7.6.4. Spain
7.6.4.1. By Drug Class
7.6.5. Italy
7.6.5.1. By Drug Class
7.6.6. Scandinavia
7.6.6.1. By Drug Class
7.6.7. Rest of Europe
7.6.7.1. By Drug Class
8. Asia Pacific Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Drug Class
8.1.1. Cytotoxic Drugs
8.1.1.1. Alkylating Agents
8.1.1.2. Antimetabolites
8.1.1.3. Others
8.1.2. Targeted Drugs
8.1.2.1. Monoclonal Antibodies
8.1.2.2. Others
8.1.3. Hormonal Drugs
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Therapy
8.2.1. Chemotherapy
8.2.2. Targeted Therapy
8.2.3. Immunotherapy
8.3. Market Analysis, Insights and Forecast – By Indication
8.3.1. Lung Cancer
8.3.2. Stomach Cancer
8.3.3. Colorectal Cancer
8.3.4. Breast Cancer
8.3.5. Prostate Cancer
8.3.6. Others
8.4. Market Analysis, Insights and Forecast – By Dosage Form
8.4.1. Solid
8.4.1.1. Tablets
8.4.1.2. Capsules
8.4.2. Liquid
8.4.3. Injectable
8.4.3.1. Prefilled Syringes
8.4.3.2. Others
8.5. Market Analysis, Insights and Forecast – By Distribution Channel
8.5.1. Hospital Pharmacies
8.5.2. Retail Pharmacies
8.5.3. Online Pharmacies
8.6. Market Analysis, Insights and Forecast – By Country/Sub-region
8.6.1. Japan
8.6.1.1. By Drug Class
8.6.2. China
8.6.2.1. By Drug Class
8.6.3. India
8.6.3.1. By Drug Class
8.6.4. Australia
8.6.4.1. By Drug Class
8.6.5. Southeast Asia
8.6.5.1. By Drug Class
8.6.6. Rest of Asia Pacific
8.6.6.1. By Drug Class
9. Latin America Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Drug Class
9.1.1. Cytotoxic Drugs
9.1.1.1. Alkylating Agents
9.1.1.2. Antimetabolites
9.1.1.3. Others
9.1.2. Targeted Drugs
9.1.2.1. Monoclonal Antibodies
9.1.2.2. Others
9.1.3. Hormonal Drugs
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Therapy
9.2.1. Chemotherapy
9.2.2. Targeted Therapy
9.2.3. Immunotherapy
9.3. Market Analysis, Insights and Forecast – By Indication
9.3.1. Lung Cancer
9.3.2. Stomach Cancer
9.3.3. Colorectal Cancer
9.3.4. Breast Cancer
9.3.5. Prostate Cancer
9.3.6. Others
9.4. Market Analysis, Insights and Forecast – By Dosage Form
9.4.1. Solid
9.4.1.1. Tablets
9.4.1.2. Capsules
9.4.2. Liquid
9.4.3. Injectable
9.4.3.1. Prefilled Syringes
9.4.3.2. Others
9.5. Market Analysis, Insights and Forecast – By Distribution Channel
9.5.1. Hospital Pharmacies
9.5.2. Retail Pharmacies
9.5.3. Online Pharmacies
9.6. Market Analysis, Insights and Forecast – By Country/Sub-region
9.6.1. Brazil
9.6.1.1. By Drug Class
9.6.2. Mexico
9.6.2.1. By Drug Class
9.6.3. Rest of Latin America
9.6.3.1. By Drug Class
10. Middle East & Africa Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Drug Class
10.1.1. Cytotoxic Drugs
10.1.1.1. Alkylating Agents
10.1.1.2. Antimetabolites
10.1.1.3. Others
10.1.2. Targeted Drugs
10.1.2.1. Monoclonal Antibodies
10.1.2.2. Others
10.1.3. Hormonal Drugs
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Therapy
10.2.1. Chemotherapy
10.2.2. Targeted Therapy
10.2.3. Immunotherapy
10.3. Market Analysis, Insights and Forecast – By Indication
10.3.1. Lung Cancer
10.3.2. Stomach Cancer
10.3.3. Colorectal Cancer
10.3.4. Breast Cancer
10.3.5. Prostate Cancer
10.3.6. Others
10.4. Market Analysis, Insights and Forecast – By Dosage Form
10.4.1. Solid
10.4.1.1. Tablets
10.4.1.2. Capsules
10.4.2. Liquid
10.4.3. Injectable
10.4.3.1. Prefilled Syringes
10.4.3.2. Others
10.5. Market Analysis, Insights and Forecast – By Distribution Channel
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Analysis, Insights and Forecast – By Country/Sub-region
10.6.1. GCC
10.6.1.1. By Drug Class
10.6.2. South Africa
10.6.2.1. By Drug Class
10.6.3. Rest of Middle East & Africa
10.6.3.1. By Drug Class
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. AbbVie, Inc.
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Novartis AG
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Pfizer Inc.
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Bristol Myers Squibb Company
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. GlaxoSmithKline plc.
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Eli Lilly and Company
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. AstraZeneca
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Sanofi
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. Bayer AG
11.2.10.1. Overview
11.2.10.2. Products & Services
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. Merck & Co., Inc.
11.2.11.1. Overview
11.2.11.2. Products & Services
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings